|
US6596535B1
(en)
|
1999-08-09 |
2003-07-22 |
Targeted Genetics Corporation |
Metabolically activated recombinant viral vectors and methods for the preparation and use
|
|
WO2001083695A2
(en)
|
2000-04-28 |
2001-11-08 |
Xiao Xiao |
Dna sequences encoding dystrophin minigenes and methods of use thereof
|
|
EP1366160B1
(en)
|
2000-10-06 |
2008-07-09 |
The Regents Of The University Of Michigan |
Mini-dystrophin nucleic acid and peptide sequences
|
|
CN103589692B
(zh)
*
|
2001-11-13 |
2018-07-24 |
宾夕法尼亚大学托管会 |
检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
EP1668143B1
(en)
|
2003-09-30 |
2013-03-20 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
|
|
US7183969B2
(en)
|
2004-12-22 |
2007-02-27 |
Raytheon Company |
System and technique for calibrating radar arrays
|
|
DE23193606T1
(de)
|
2005-04-07 |
2024-02-15 |
The Trustees Of The University Of Pennsylvania |
Verfahren zur erhöhung der funktion eines aav-vektors
|
|
JP4495210B2
(ja)
|
2005-06-09 |
2010-06-30 |
パナソニック株式会社 |
振幅誤差補償装置及び直交度誤差補償装置
|
|
WO2008088895A2
(en)
|
2007-01-18 |
2008-07-24 |
University Of Missouri-Columbia |
Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma
|
|
AU2009215987B2
(en)
|
2008-02-19 |
2015-01-22 |
Uniqure Ip B.V. |
Optimisation of expression of parvoviral rep and cap proteins in insect cells
|
|
US8236557B2
(en)
|
2008-05-28 |
2012-08-07 |
University Of Missouri-Columbia |
Hybrid-AAV vectors to deliver large gene expression cassette
|
|
JP2013516389A
(ja)
|
2009-01-06 |
2013-05-13 |
ダイアックス コーポレーション |
カリクレイン阻害剤による粘膜炎治療
|
|
DK2425000T3
(da)
|
2009-04-30 |
2019-05-13 |
Univ Pennsylvania |
Sammensætninger rettet mod ledende luftvejsceller omfattende konstrukter af adeno-associeret virus
|
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
US8628966B2
(en)
|
2010-04-30 |
2014-01-14 |
City Of Hope |
CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
|
|
US10738326B2
(en)
|
2010-10-27 |
2020-08-11 |
Jichi Medical University |
Adeno-associated virus vector for gene transfer to nervous system cells
|
|
KR102011156B1
(ko)
|
2011-01-06 |
2019-08-16 |
다이액스 코포레이션 |
혈장 칼리크레인 결합 단백질
|
|
CA2826273C
(en)
|
2011-02-10 |
2021-11-02 |
The University Of North Carolina At Chapel Hill |
Viral vectors with modified transduction profiles and methods of making and using the same
|
|
DK3693025T3
(da)
|
2011-04-22 |
2022-01-10 |
Univ California |
Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf
|
|
EP3795581A3
(en)
|
2011-08-24 |
2021-06-09 |
The Board of Trustees of the Leland Stanford Junior University |
New avv capsid proteins for nucleic acid transfer
|
|
EP3470523A1
(en)
|
2012-05-09 |
2019-04-17 |
Oregon Health & Science University |
Adeno associated virus plasmids and vectors
|
|
US9624282B2
(en)
|
2012-11-26 |
2017-04-18 |
The Curators Of The University Of Missouri |
Microdystrophin peptides and methods for treating muscular dystrophy using the same
|
|
EP4234583A3
(en)
|
2013-01-20 |
2024-01-24 |
Takeda Pharmaceutical Company Limited |
Evaluation and treatment of bradykinin-mediated disorders
|
|
DK2946206T3
(en)
|
2013-01-20 |
2019-04-15 |
Dyax Corp |
EVALUATION, ANALYSIS AND TREATMENT OF PKAL-MEDIATED DISORDERS
|
|
EP2970946A4
(en)
|
2013-03-13 |
2016-09-07 |
Philadelphia Children Hospital |
ADENOASSOZED VIRUS VECTORS AND METHOD FOR USE THEREOF
|
|
JP2016513682A
(ja)
|
2013-03-15 |
2016-05-16 |
ダイアックス コーポレーション |
抗血漿カリクレイン抗体
|
|
US9862945B2
(en)
|
2013-04-20 |
2018-01-09 |
Research Institute At Nationwide Children's Hospital |
Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs
|
|
NZ716102A
(en)
|
2013-07-22 |
2021-12-24 |
The Children’S Hospital Of Philadelphia |
Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
|
|
EP3564379A1
(en)
|
2013-09-13 |
2019-11-06 |
California Institute of Technology |
Selective recovery
|
|
HUE052676T2
(hu)
|
2013-10-11 |
2021-05-28 |
Massachusetts Eye & Ear Infirmary |
Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik
|
|
RS61993B1
(sr)
|
2013-12-03 |
2021-07-30 |
Hookipa Biotech Gmbh |
Cmv vakcine
|
|
ES3065185T3
(en)
|
2014-01-21 |
2026-05-04 |
Takeda Pharmaceuticals Co |
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
IL247942B
(en)
|
2014-03-27 |
2022-09-01 |
Dyax Corp |
Compositions and methods for drops in macular edema as a result of diabetes
|
|
US10746742B2
(en)
|
2014-04-25 |
2020-08-18 |
Oregon Health & Science University |
Methods of viral neutralizing antibody epitope mapping
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
EP2960336A1
(en)
|
2014-06-27 |
2015-12-30 |
Genethon |
Efficient systemic treatment of dystrophic muscle pathologies
|
|
WO2016049230A1
(en)
|
2014-09-24 |
2016-03-31 |
City Of Hope |
Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
|
|
JP6754361B2
(ja)
*
|
2014-12-16 |
2020-09-09 |
ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ |
若年型バッテン病のための遺伝子療法
|
|
CA2972800A1
(en)
|
2015-01-02 |
2016-07-07 |
Dyax Corp. |
Bispecific antibodies against plasma kallikrein and factor xii
|
|
WO2016115543A2
(en)
|
2015-01-16 |
2016-07-21 |
University Of Washington |
Novel micro-dystrophins and related methods of use
|
|
KR102554850B1
(ko)
*
|
2015-02-06 |
2023-07-13 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
최적화된 인간 응고 인자 viii 유전자 발현 카세트 및 그의 용도
|
|
CA3290174A1
(en)
|
2015-03-30 |
2026-03-02 |
Takeda Pharmaceutical Company Limited |
Plasma kallikrein inhibitors and uses thereof for preventing hereditary angioedema attack
|
|
GB201507842D0
(en)
*
|
2015-05-07 |
2015-06-17 |
New Royal Holloway & Bedford |
Production of large-sized microdystrophins in an AAV-based vector configuration
|
|
JP6665466B2
(ja)
|
2015-09-26 |
2020-03-13 |
日亜化学工業株式会社 |
半導体発光素子及びその製造方法
|
|
EA201891002A1
(ru)
|
2015-10-19 |
2018-11-30 |
Дайэкс Корп. |
Иммунологический анализ для определения расщепленного высокомолекулярного кининогена
|
|
WO2017070491A1
(en)
|
2015-10-23 |
2017-04-27 |
Applied Genetic Technologies Corporation |
Ophthalmic formulations
|
|
US11286307B2
(en)
|
2015-12-11 |
2022-03-29 |
Takeda Pharmaceutical Company Limited |
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
|
|
EP4085934A1
(en)
*
|
2015-12-11 |
2022-11-09 |
The Trustees of The University of Pennsylvania |
Gene therapy for treating familial hypercholesterolemia
|
|
WO2017181011A1
(en)
|
2016-04-15 |
2017-10-19 |
Research Institute At Nationwide Children's Hospital |
Adeno-associated virus vector delivery of microrna-29 to treat muscular dystrophy
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
US11596699B2
(en)
|
2016-04-29 |
2023-03-07 |
CureVac SE |
RNA encoding an antibody
|
|
WO2017223128A1
(en)
|
2016-06-21 |
2017-12-28 |
The Curators Of The University Of Missouri |
Modified dystrophin proteins
|
|
CA2971303C
(en)
|
2016-06-21 |
2026-03-03 |
Bamboo Therapeutics, Inc. |
Optimized mini-dystrophin genes and expression cassettes and their use
|
|
JP7186400B2
(ja)
|
2016-08-30 |
2022-12-09 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
ゲノム的に再コードした生物におけるセレノ－生物製剤の製造
|
|
WO2018053244A1
(en)
|
2016-09-16 |
2018-03-22 |
Dyax Corp. |
Protein biomarkers for diseases associated with the contact activation system
|
|
KR102569559B1
(ko)
|
2016-09-16 |
2023-08-23 |
다케다 파머수티컬 컴패니 리미티드 |
유전성 혈관부종에 대한 rna 바이오마커
|
|
IL314752A
(en)
|
2016-09-16 |
2024-10-01 |
Takeda Pharmaceuticals Co |
Metabolite biomarkers for diseases associated with the contact activation system
|
|
CN110997923B
(zh)
|
2017-03-17 |
2024-01-02 |
全国儿童医院研究所 |
腺相关病毒载体递送肌肉特异性微肌营养不良蛋白以治疗肌营养不良症
|
|
US11338045B2
(en)
|
2017-03-17 |
2022-05-24 |
Newcastle University |
Adeno-associated virus vector delivery of a fragment of micro-dystrophin to treat muscular dystrophy
|
|
US11447546B2
(en)
|
2017-07-20 |
2022-09-20 |
Nbe-Therapeutics Ag |
Human antibodies binding to ROR2
|
|
KR20200067195A
(ko)
|
2017-10-18 |
2020-06-11 |
리젠엑스바이오 인크. |
완전-인간 번역후 변형된 항체 치료제
|
|
CA3086942A1
(en)
|
2018-02-07 |
2019-08-15 |
Genethon |
Hybrid regulatory elements
|
|
AU2019221642A1
(en)
|
2018-02-14 |
2020-07-09 |
Generation Bio Co. |
Non-viral DNA vectors and uses thereof for antibody and fusion protein production
|
|
WO2019195362A1
(en)
|
2018-04-03 |
2019-10-10 |
Curators Of The University Of Missouri |
Hinges 1 and/or 4 modified dystrophins for dystrophinopathy therapy
|
|
CA3099958A1
(en)
|
2018-04-16 |
2019-10-24 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating duchenne muscular dystrophy
|
|
IL324506A
(en)
|
2018-06-18 |
2026-01-01 |
Res Inst Nationwide Childrens Hospital |
Adeno-associated virus vector for delivery of muscle-specific microdystrophin for the treatment of muscular dystrophy
|
|
EP3843840A1
(en)
|
2018-08-30 |
2021-07-07 |
Dyax Corp. |
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
|
|
CN113613668A
(zh)
|
2018-10-24 |
2021-11-05 |
百时美施贵宝公司 |
小型化肌营养不良蛋白及其用途
|
|
JP2022510218A
(ja)
|
2018-11-30 |
2022-01-26 |
メモリアル スローン ケタリング キャンサー センター |
ヘテロ二量体四価特異性抗体およびこれらの使用
|
|
KR20210142006A
(ko)
|
2019-03-14 |
2021-11-23 |
다케다 파머수티컬 컴패니 리미티드 |
유전성 혈관부종 발작의 치료를 위한 혈장 칼리크레인 저해제 및 이의 용도
|
|
EP3947427A1
(en)
|
2019-03-25 |
2022-02-09 |
Genethon |
Production of large-sized quasidystrophins using overlapping aav vectors
|
|
GB201905552D0
(en)
|
2019-04-18 |
2019-06-05 |
Kymab Ltd |
Antagonists
|
|
US20220195462A1
(en)
|
2019-04-24 |
2022-06-23 |
Regenxbio Inc. |
Fully-human post-translationally modified antibody therapeutics
|
|
EP3966227A1
(en)
|
2019-05-07 |
2022-03-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation
|
|
US20230038502A1
(en)
|
2019-06-11 |
2023-02-09 |
Shire Human Genetic Therapies, Inc. |
Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein
|
|
WO2020261178A1
(en)
|
2019-06-27 |
2020-12-30 |
Pfizer Inc. |
Methods of treating duchenne muscular dystrophy using aav mini-dystrophin gene therapy
|
|
EP4004214A1
(en)
|
2019-07-26 |
2022-06-01 |
RegenxBio Inc. |
Engineered nucleic acid regulatory element and methods of uses thereof
|
|
IL307902A
(en)
|
2021-04-26 |
2023-12-01 |
Regenxbio Inc |
Microdystrophin gene therapy administration for treatment of dystrophinopathies
|
|
US20240358857A1
(en)
|
2021-05-11 |
2024-10-31 |
Regenxbio Inc. |
Treatment of duchenne muscular dystrophy and combinations thereof
|
|
AU2022313258A1
(en)
|
2021-07-19 |
2024-02-08 |
New York University |
Auf1 combination therapies for treatment of muscle degenerative disease
|